See more : Menon Bearings Limited (MENONBE.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Bumrungrad Hospital Public Company Limited (BUGDF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bumrungrad Hospital Public Company Limited, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Xilinmen Furniture Co.,Ltd (603008.SS) Income Statement Analysis – Financial Results
- Microlise Group plc (SAAS.L) Income Statement Analysis – Financial Results
- Clarke Inc. (CKI.TO) Income Statement Analysis – Financial Results
- China Merchants Port Holdings Company Limited (0144.HK) Income Statement Analysis – Financial Results
- Bingo Software Co., Ltd. (688227.SS) Income Statement Analysis – Financial Results
Bumrungrad Hospital Public Company Limited (BUGDF)
About Bumrungrad Hospital Public Company Limited
Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.38B | 20.72B | 12.46B | 12.36B | 18.47B | 18.33B | 18.35B | 17.91B | 17.66B | 15.63B | 14.35B | 12.98B | 11.01B | 10.07B | 9.34B | 8.88B | 9.41B | 7.90B | 6.81B | 5.81B | 4.62B |
| Cost of Revenue | 12.89B | 11.10B | 7.73B | 7.68B | 10.29B | 10.05B | 10.46B | 10.40B | 10.40B | 9.50B | 8.84B | 8.23B | 6.60B | 5.94B | 5.55B | 5.32B | 5.12B | 4.78B | 4.15B | 3.66B | 2.94B |
| Gross Profit | 12.48B | 9.62B | 4.73B | 4.68B | 8.19B | 8.28B | 7.89B | 7.51B | 7.26B | 6.13B | 5.51B | 4.75B | 4.42B | 4.13B | 3.78B | 3.56B | 4.29B | 3.12B | 2.66B | 2.15B | 1.68B |
| Gross Profit Ratio | 49.19% | 46.43% | 37.96% | 37.90% | 44.33% | 45.18% | 42.99% | 41.95% | 41.13% | 39.25% | 38.41% | 36.59% | 40.09% | 40.97% | 40.53% | 40.05% | 45.61% | 39.52% | 39.10% | 36.95% | 36.38% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.50B | 3.21B | 2.94B | 3.07B | 3.26B | 2.90B | 3.13B | 3.13B | 3.11B | 2.81B | 2.53B | 2.30B | 0.00 | 1.66B | 1.53B | 1.40B | 1.36B | 1.15B | 981.99M | 765.77M | 629.55M |
| Selling & Marketing | 684.88M | 586.33M | 358.45M | 328.04M | 486.90M | 386.07M | 311.65M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 4.18B | 3.80B | 3.30B | 3.39B | 3.75B | 3.29B | 3.13B | 3.13B | 3.11B | 2.81B | 2.53B | 2.30B | 1.86B | 1.66B | 1.53B | 1.40B | 1.36B | 1.15B | 981.99M | 765.77M | 629.55M |
| Other Expenses | -198.82M | -186.97M | -144.10M | -77.83M | -84.89M | 61.76M | 66.89M | 63.93M | 60.14M | 58.22M | 95.40M | 126.34M | 647.81M | 595.84M | 539.27M | 459.36M | 777.87M | 352.52M | 307.35M | 254.00M | 247.87M |
| Operating Expenses | 3.98B | 3.61B | 3.15B | 3.32B | 3.67B | 3.20B | 3.05B | 3.06B | 3.02B | 2.71B | 2.43B | 2.20B | 2.51B | 2.26B | 2.06B | 1.86B | 2.13B | 1.50B | 1.29B | 1.02B | 877.42M |
| Cost & Expenses | 16.88B | 14.71B | 10.88B | 10.99B | 13.95B | 13.24B | 13.51B | 13.46B | 13.42B | 12.20B | 11.27B | 10.44B | 9.11B | 8.20B | 7.62B | 7.18B | 7.25B | 6.28B | 5.43B | 4.68B | 3.82B |
| Interest Income | 140.95M | 45.95M | 68.78M | 127.89M | 159.07M | 125.40M | 103.25M | 113.30M | 137.95M | 137.78M | 154.14M | 98.37M | 29.84M | 1.94M | 1.61M | 6.27M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 2.39M | 3.55M | 119.76M | 127.62M | 127.01M | 165.15M | 149.85M | 215.17M | 186.50M | 186.03M | 147.87M | 240.75M | 189.43M | 68.20M | 90.93M | 114.43M | 110.51M | 109.95M | 106.87M | 118.89M | 120.55M |
| Depreciation & Amortization | 1.10B | 1.12B | 1.18B | 1.22B | 1.22B | 1.18B | 1.21B | 1.14B | 1.04B | 1.04B | 882.27M | 709.08M | 647.81M | 595.84M | 539.27M | 459.36M | 407.63M | 342.09M | 291.82M | 243.37M | 243.49M |
| EBITDA | 9.74B | 7.17B | 2.77B | 2.72B | 5.89B | 6.39B | 6.15B | 5.71B | 5.44B | 4.60B | 4.12B | 3.45B | 2.59B | 2.46B | 2.32B | 2.20B | 2.57B | 2.07B | 1.77B | 1.49B | 1.17B |
| EBITDA Ratio | 38.37% | 34.62% | 22.58% | 21.95% | 31.95% | 34.85% | 33.51% | 31.87% | 30.78% | 29.46% | 28.73% | 26.56% | 23.49% | 24.13% | 24.70% | 24.34% | 28.44% | 26.23% | 26.01% | 25.63% | 25.27% |
| Operating Income | 8.50B | 6.01B | 1.52B | 1.37B | 4.68B | 5.21B | 4.94B | 4.57B | 4.39B | 3.56B | 3.24B | 2.74B | 1.94B | 1.83B | 1.77B | 1.70B | 2.16B | 1.62B | 1.37B | 1.13B | 803.62M |
| Operating Income Ratio | 33.50% | 28.99% | 12.19% | 11.11% | 25.33% | 28.41% | 26.93% | 25.51% | 24.87% | 22.78% | 22.58% | 21.10% | 17.61% | 18.21% | 18.93% | 19.16% | 22.94% | 20.51% | 20.15% | 19.39% | 17.39% |
| Total Other Income/Expenses | 137.66M | 41.90M | -63.39M | -2.11M | -145.45M | -44.94M | -52.23M | -77.21M | -128.03M | -4.71M | -87.57M | -77.90M | -31.43M | 193.90M | -43.69M | -71.18M | -110.51M | -109.95M | -106.87M | -118.89M | 0.00 |
| Income Before Tax | 8.64B | 6.05B | 1.46B | 1.37B | 4.53B | 5.04B | 4.78B | 4.38B | 4.25B | 3.42B | 3.15B | 3.36B | 2.09B | 1.77B | 1.69B | 1.63B | 2.16B | 1.62B | 1.37B | 1.13B | 803.62M |
| Income Before Tax Ratio | 34.04% | 29.19% | 11.68% | 11.09% | 24.54% | 27.48% | 26.07% | 24.44% | 24.07% | 21.88% | 21.93% | 25.86% | 19.01% | 17.54% | 18.10% | 18.36% | 22.94% | 20.51% | 20.15% | 19.39% | 17.39% |
| Income Tax Expense | 1.58B | 1.07B | 215.85M | 149.68M | 773.19M | 880.20M | 840.96M | 773.85M | 823.32M | 685.42M | 625.41M | 689.82M | 506.15M | 507.34M | 444.40M | 439.85M | 445.38M | 432.14M | 217.91M | 128.64M | 137.13M |
| Net Income | 7.01B | 4.94B | 1.22B | 1.20B | 3.75B | 4.15B | 3.94B | 3.63B | 3.44B | 2.73B | 2.52B | 2.67B | 1.59B | 1.26B | 1.25B | 1.19B | 1.61B | 1.10B | 1.05B | 934.55M | 666.49M |
| Net Income Ratio | 27.61% | 23.83% | 9.76% | 9.74% | 20.29% | 22.66% | 21.50% | 20.24% | 19.46% | 17.47% | 17.57% | 20.54% | 14.42% | 12.50% | 13.34% | 13.41% | 17.06% | 13.88% | 15.47% | 16.09% | 14.43% |
| EPS | 8.08 | 6.21 | 1.53 | 1.54 | 5.14 | 4.79 | 5.41 | 4.98 | 4.72 | 3.75 | 3.46 | 3.51 | 2.18 | 1.73 | 1.71 | 1.64 | 2.20 | 1.51 | 1.45 | 1.36 | 1.34 |
| EPS Diluted | 8.08 | 5.69 | 1.40 | 1.39 | 4.32 | 4.79 | 4.55 | 4.18 | 3.96 | 3.15 | 2.91 | 2.95 | 1.83 | 1.45 | 1.44 | 1.37 | 1.85 | 1.26 | 1.21 | 1.08 | 0.78 |
| Weighted Avg Shares Out | 867.14M | 794.84M | 794.59M | 781.65M | 728.83M | 866.78M | 728.68M | 728.64M | 728.62M | 728.59M | 728.53M | 728.39M | 728.38M | 728.33M | 728.30M | 728.26M | 728.12M | 727.80M | 727.63M | 686.00M | 499.16M |
| Weighted Avg Shares Out (Dil) | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.42M | 867.41M | 867.41M | 867.41M | 867.41M | 867.41M | 863.08M | 857.91M |
Source: https://incomestatements.info
Category: Stock Reports